Laboratorios Cinfa S.A. — Sponsor Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

1 Recruiting

14 Completed trials

2 Countries active

1 Unique IMPs

100% Results reported

Other

Phase I (Other): 1 Other: 14

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cardiac failure 1 Type 2 diabetes mellitus 1 Pain 1 Chronic kidney disease 1

Top IMPs

PERAMPANEL 2

All trials

15 total

Bioequivalence of Tramadol retard 200 mg Prolonged-Release Tablets in Healthy Subjects Under Fed Conditions Recruiting

2026-525780-41-00 1 country
Multiple-dose, open-label, laboratory blinded, randomized, 2-period, 2-sequence, crossover, steady-state bioequivalence study comparing the … Ended

2026-526102-33-00 1 country
Multiple-Dose Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended

2025-522627-10-00 1 country
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fed Conditions. Ended

2025-522624-27-00 1 country
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-521732-11-00 1 country
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-524035-39-00 1 country
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended

2025-522626-12-00 1 country
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the comparati… Ended

2025-522254-39-00 Phase I (Other) 1 country
The bioavailability study of Dapagliflozin Ended

2025-522234-31-00 1 country
Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-513480-37-00 1 country
Bioequivalence of Vortioxetine 5 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions. Ended

2023-509422-21-00 1 country
Bioequivalence of Vortioxetine 20 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions Ended

2023-509419-10-00 1 country
Bioequivalence of Apixaban 5 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions. Ended

2023-506844-18-00 1 country
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-504132-18-00 1 country PERAMPANEL
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P… Ended

2023-503345-59-00 1 country PERAMPANEL

Showing 1–15 of 15 trials

← All sponsors A–Z